T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Abstract
Bone resorption is regulated by the immune system, where T-cell expression of RANKL (receptor activator of nuclear factor (NF)-kappaB ligand), a member of the tumour-necrosis factor family that is essential for osteoclastogenesis, may contribute to pathological conditions, such as autoimmune arthritis. However, whether activated T cells maintain bone homeostasis by counterbalancing the action of RANKL remains unknown. Here we show that T-cell production of interferon (IFN)-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL-RANK signalling pathway. IFN-gamma induces rapid degradation of the RANK adapter protein, TRAF6 (tumour necrosis factor receptor-associated factor 6), which results in strong inhibition of the RANKL-induced activation of the transcription factor NF-kappaB and JNK. This inhibition of osteoclastogenesis is rescued by overexpressing TRAF6 in precursor cells, which indicates that TRAF6 is the target critical for the IFN-gamma action. Furthermore, we provide evidence that the accelerated degradation of TRAF6 requires both its ubiquitination, which is initiated by RANKL, and IFN-gamma-induced activation of the ubiquitin-proteasome system. Our study shows that there is cross-talk between the tumour necrosis factor and IFN families of cytokines, through which IFN-gamma provides a negative link between T-cell activation and bone resorption. Our results may offer a therapeutic approach to treat the inflammation-induced tissue breakdown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synovial cells isolated from rheumatoid joints have been found to express RANKL, RANK, and OPG (90, 412-415).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [415]
Citations
Cites
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
The Proteasome: Paradigm of a Self-Compartmentalizing Protease
Baumeister, W., Walz, J., Zühl, F., & Seemüller, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80929-0 · Cited by 1,494
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Self-citation
Research works printed but not linked: 2
- Takayanagi, H. et al. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43, 259–269 (2000). · doi:10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w
- Gravallese, E. M. et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250–258 (2000). · doi:10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p
Cited by
Items 201–300 of 1,001
Molecular mechanisms underlying osteoclast formation and activation
Troen, B. R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00069-x · Cited by 184
Colucci, S., Brunetti, G., Rizzi, R., Zonno, A., Mori, G., Colaianni, G., Del Prete, D., Faccio, R., Liso, A., Capalbo, S., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0474 · Cited by 146
Estrogen deficiency, T cells and bone loss
Pacifici, R. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.06.008 · Cited by 146
Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD
Ciucci, T., Ibáñez, L., Boucoiran, A., Birgy-Barelli, E., Pène, J., Abou-Ezzi, G., Arab, N., Rouleau, M., Hébuterne, X., Yssel, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-306947 · Cited by 145
Cousminer, D. L., Wagley, Y., Pippin, J. A., Elhakeem, A., Way, G. P., Pahl, M. C., McCormack, S. E., Chesi, A., Mitchell, J. A., Kindler, J. M., et al. (2021) · Genome Biology · doi:10.1186/s13059-020-02207-9 · Cited by 144
Zhao, B., & Ivashkiv, L. B. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3379 · Cited by 144
Schulze, J., Bickert, T., Beil, F. T., Zaiss, M. M., Albers, J., Wintges, K., Streichert, T., Klaetschke, K., Keller, J., Hissnauer, T.-N., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.269 · Cited by 143
Role of T cells in ovariectomy induced bone loss—revisited
Pacifici, R. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1500 · Cited by 142
Kollet, Ó., Dar, A., & Lapidot, T. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141631 · Cited by 157
LaBranche, T. P., Jesson, M. I., Radi, Z. A., Storer, C. E., Guzova, J. A., Bonar, S. L., Thompson, J., Happa, F. A., Stewart, Z. S., Zhan, Y., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34649 · Cited by 147
Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis
Zhang, W., Gao, R., Rong, X., Zhu, S., Cui, Y., Liu, H., & Li, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965258 · Cited by 174
Kim, H. J., Chang, E., Kim, H., Lee, S. B., Kim, H.-D., Kim, G. S., & Kim, H. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.066 · Cited by 150
Okamoto, K., & Takayanagi, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031245 · Cited by 162
Self-citationKotake, S., Nanke, Y., Mogi, M., Kawamoto, M., Furuya, T., Yago, T., Kobashigawa, T., Togari, A., & Kamatani, N. (2005) · European Journal of Immunology · doi:10.1002/eji.200526141 · Cited by 136
Cytokine-mediated immunomodulation of osteoclastogenesis
Zhou, P., Zheng, T., & Zhao, B. (2022) · Bone · doi:10.1016/j.bone.2022.116540 · Cited by 160
The multiple faces of autoimmune-mediated bone loss
Schett, G. A., & David, J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.190 · Cited by 147
Kwak, H. B., Ha, H., Kim, H., Lee, J., Kim, H. S., Lee, S., Kim, H., Kim, J. Y., Kim, H., Song, Y. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23372 · Cited by 133
Molecular biology of bone remodelling.
Rucci, N. (2008) · PubMed Central · Cited by 272
The function of dendritic cells in modulating the host response
Song, L., Dong, G., Guo, L., & Graves, D. T. (2017) · Molecular Oral Microbiology · doi:10.1111/omi.12195 · Cited by 143
Osteoclasts and odontoclasts: signaling pathways to development and disease
Wang, Z., & McCauley, L. K. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01718.x · Cited by 149
TGF-beta1 on osteoimmunology and the bone component cells
Kasagi, S., & Chen, W. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-4 · Cited by 146
Regulatory roles and molecular signaling of TNF family members in osteoclasts
Feng, X. (2005) · Gene · doi:10.1016/j.gene.2005.01.014 · Cited by 152
Arron, J. R., Vologodskaia, M., Wong, B. R., Naramura, M., Kim, N., Gu, H., & Choi, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100414200 · Cited by 127
Replicative senescence of CD8 T cells: Effect on human ageing
Effros, R. B. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.024 · Cited by 127
Osteoclast formation and differentiation: an overview.
Soysa, N. S., Alles, N., Aoki, K., & Ohya, K. (2012) · PubMed · Cited by 150
Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles
Coutant, F., & Miossec, P. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.147 · Cited by 134
Scaffold strategies for modulating immune microenvironment during bone regeneration
He, J., Chen, G., Liu, M., Xu, Z., Chen, H., Yang, L., & Lv, Y. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110411 · Cited by 134
RANKL and osteoimmunology in periodontitis
Tsukasaki, M. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01165-3 · Cited by 142
Lee, M. S., Kim, H. S., Yeon, J.-T., Choi, S.-W., Chun, C. H., Kwak, H. B., & Oh, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804314 · Cited by 125
Takahashi, N., Udagawa, N., Takami, M., & Suda, T. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1/50109-8 · Cited by 161
Rea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123
Stress‐induced decrease in TRAF2 stability is mediated by Siah2
Habelhah, H., Frew, I. J., Laine, A., Janes, P. W., Relaix, F., Sassoon, D. A., Bowtell, D. D. L., & Ronai, Z. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf576 · Cited by 124
A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease
Esfandiari, E., McInnes, I. B., Lindop, G. B. M., Huang, F., Field, M., Komai‐Koma, M., Wei, X., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5338 · Cited by 129
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa, N., Kotake, S., Kamatani, N., Takahashi, N., & Suda, T. (2002) · Arthritis Research · doi:10.1186/ar431 · Cited by 141
Park‐Min, K., Ji, J.-D., Antoniv, T. T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M. C., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804165 · Cited by 130
Zaiss, M. M., Sarter, K., Hess, A., Engelke, K., Böhm, C., Nimmerjahn, F., Voll, R., Schett, G., & David, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27535 · Cited by 122
Novince, C. M., Whittow, C. R., Aartun, J. D., Hathaway, J. D., Poulides, N., Chavez, M. B., Steinkamp, H. M., Kirkwood, K. A., Huang, E., Westwater, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06126-x · Cited by 121
Rheumatoid Arthritis in the View of Osteoimmunology
Auréal, M., Machuca‐Gayet, I., & Coury, F. (2020) · Biomolecules · doi:10.3390/biom11010048 · Cited by 135
Schett, G., & Teitelbaum, S. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090533 · Cited by 119
Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF
Zhang, J., Zhao, H., Chen, J., Xia, B., Jin, Y., Wei, W., Shen, J., & Huang, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.047 · Cited by 133
Maekawa, T., Hosur, K., Abe, T., Kantarci, A., Ziogas, A., Wang, B., Van Dyke, T. E., Chavakis, T., & Hajishengallis, G. (2015) · Nature Communications · doi:10.1038/ncomms9272 · Cited by 119
TRAF Molecules in Inflammation and Inflammatory Diseases
Lalani, A., Zhu, S., Gokhale, S., Jin, J., & Xie, P. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0117-y · Cited by 132
Osteoimmunology in Periodontitis and Orthodontic Tooth Movement
Alghamdi, B., Jeon, H. H., Ni, J., Qiu, D., Liu, A., Hong, J. J., Ali, M., Wang, A., Troka, M. E., & Graves, D. T. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00774-x · Cited by 147
Pathological role of osteoclast costimulation in arthritis-induced bone loss
Ochi, S., Shinohara, M., Sato, K., Gober, H.-J., Koga, T., Kodama, T., Takai, T., Miyasaka, N., & Takayanagi, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701971104 · Cited by 119
Self-citationReview: Immune cells and mediators of inflammatory arthritis
Schett, G. A. (2008) · Autoimmunity · doi:10.1080/08916930701694717 · Cited by 134
The Contribution of the Immune System in Bone Metastasis Pathogenesis
Xiang, L., & Gilkes, D. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040999 · Cited by 126
Osteoimmunology: cytokines and the skeletal system
Lee, S., Kim, T. S., Choi, Y., & Lorenzo, J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.7.495 · Cited by 127
Loss of Ubiquitin-Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations
Cavey, J. R., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Ciani, B., Searle, M. S., & Layfield, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041205 · Cited by 116
Pacifici, R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.027 · Cited by 115
Guillerey, C., Nakamura, K., Vučković, S., Hill, G. R., & Smyth, M. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2135-z · Cited by 129
Self-citationGiuliani, N., Colla, S., & Rizzoli, V. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.03.015 · Cited by 128
Speziani, C., Rivollier, A., Gallois, A., Coury, F., Mazzorana, M., Azocar, O., Flacher, M., Bella, C., Tebib, J., Jurdic, P., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636534 · Cited by 112
Maruyama, K., Muramatsu, H., Ishiguro, N., & Muramatsu, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20175 · Cited by 123
Mechanisms involved in normal and pathological osteoclastogenesis
Park‐Min, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2817-9 · Cited by 133
Duque, G., Huang, D. C., Macoritto, M., Rivas, D., Yang, X. F., Ste-Marie, L. G., & Kremer, R. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0886 · Cited by 109
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
Sordillo, E. M., & Pearse, R. N. (2003) · Cancer · doi:10.1002/cncr.11134 · Cited by 114
Cline-Smith, A., Axelbaum, A., Shashkova, E., Chakraborty, M., Sanford, J., Panesar, P., Peterson, M., Cox, L., Baldan, A., Veis, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3966 · Cited by 108
Dar, H. Y., Pal, S., Shukla, P., Mishra, P. K., Tomar, G. B., Chattopadhyay, N., & Srivastava, R. K. (2018) · Nutrition · doi:10.1016/j.nut.2018.02.013 · Cited by 108
Where Do T Cells Stand in Rheumatoid Arthritis?
Fournier, C. (2005) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.12.012 · Cited by 111
The immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 129
Self-citationBench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation
Xie, Y., Zhang, L., Xiong, Q., Gao, Y., Ge, W., & Tang, P. (2019) · Bone Research · doi:10.1038/s41413-019-0066-7 · Cited by 119
The Role of Mast Cells in Bone Metabolism and Bone Disorders
Ragipoglu, D., Dudeck, A., Haffner-Luntzer, M., Voss, M., Kroner, J., Ignatius, A., & Fischer, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00163 · Cited by 105
Kim, H., Choi, H. K., Shin, J. H., Kim, K., Huh, J. Y., Lee, S. A., Ko, C., Kim, H.-S., Shin, H.-I., Lee, H. J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36809 · Cited by 111
T Lymphocyte–Deficient Mice Lose Trabecular Bone Mass With Ovariectomy
Lee, S.-K., Kadono, Y., Okada, F., Jacquin, C., Koczon-Jaremko, B., Gronowicz, G., Adams, D. J., Aguila, H. L., Choi, Y., & Lorenzo, J. A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060726 · Cited by 106
Tu, J., Huang, W., Zhang, W., Mei, J., & Zhu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655477 · Cited by 105
Regulation of TRAF2 Signaling by Self-induced Degradation
Brown, K. D., Hostager, B. S., & Bishop, G. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111522200 · Cited by 105
Bandow, K., Nishikawa, Y., Ohnishi, T., Kakimoto, K., Soejima, K., Iwabuchi, S., Kuroe, K., & Matsuguchi, T. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20944 · Cited by 120
Cytokines regulating osteoclast formation and function
Lee, S.-K., & Lorenzo, J. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231911.42666.78 · Cited by 104
Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis
Yamaguchi, T., Movilă, A., Kataoka, S., Wisitrasameewong, W., Ruiz‐Torruella, M., Murakoshi, M., Murakami, S., & Kawai, T. (2016) · Infection and Immunity · doi:10.1128/iai.00461-16 · Cited by 113
Lei, L., Liu, Z., Yuan, P., Jin, R., Wang, X., Jiang, T. X., & Chen, X. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00025a · Cited by 108
Molecular determinants for the polarization of macrophage and osteoclast
Yang, D., & Wan, Y. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00754-3 · Cited by 107
Cafiero, C., Spagnuolo, G., Marenzi, G., Martuscelli, R., Colamaio, M., & Leuci, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071488 · Cited by 141
The Rising Era of “Immunoporosis”: Role of Immune System in the Pathophysiology of Osteoporosis
Srivastava, R. K., & Sapra, L. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351918 · Cited by 117
Danks, L., & Takayanagi, H. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt049 · Cited by 119
Self-citationOsteocytes regulate senescence of bone and bone marrow
Ding, P., Gao, C., Gao, Y., Liu, D., Li, H., Xu, J., Chen, X., Huang, Y., Zhang, C., Zheng, M., et al. (2022) · eLife · doi:10.7554/elife.81480 · Cited by 102
Pineda, M. A., McGrath, M. A., Smith, P. C., Al‐Riyami, L., Rzepecka, J., Gracie, J. A., Harnett, W., & Harnett, M. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34581 · Cited by 102
Regulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 119
Self-citationAlbrektsson, T. O., Jemt, T., Mölne, J., Tengvall, P., & Wennerberg, A. (2018) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12711 · Cited by 108
Ahuja, S. S., Zhao, S., Bellido, T., Plotkin, L. I., Jimenez, F., & Bonewald, L. F. (2003) · Endocrinology · doi:10.1210/en.2002-221136 · Cited by 101
Marriott, I. (2004) · Immunologic Research · doi:10.1385/ir:30:3:291 · Cited by 104
Immune regulation of bone loss by Th17 cells
Adamopoulos, I. E., & Bowman, E. P. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2502 · Cited by 99
Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins
Place, D. E., Malireddi, R. K. S., Kim, J.-E., Vogel, P., Yamamoto, M., & Kanneganti, T. (2021) · Nature Communications · doi:10.1038/s41467-020-20807-8 · Cited by 110
Melatonin effects on bone: Implications for use as a therapy for managing bone loss
Munmun, F., & Witt‐Enderby, P. A. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12749 · Cited by 105
JMJD family proteins in cancer and inflammation
Wang, M., Jianxin, X., Hong, W., Chen, S., & Huashan, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01145-1 · Cited by 116
Stolina, M., Adamu, S., Ominsky, M., Dwyer, D., Asuncion, F., Geng, Z., Middleton, S., Brown, H., Pretorius, J., Schett, G., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050601 · Cited by 99
“In arthritic joints, RANKL is generated by activated synovial fibroblasts and activated T lymphocytes.((7,16,17)) Several lines of evidence convincingly show that RANKL is required for bone Drs Bolon and Schett serve as consultants for Amgen Inc.”
BackgroundRANK, RANKL and osteoprotegerin in arthritic bone loss
Bezerra, M. C., de Carvalho, J. F., Prokopowitsch, A. S., & Pereira, R. M. R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000200004 · Cited by 115
Ofotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 107
Impact of Bacterial Infections on Osteogenesis: Evidence From In Vivo Studies
Croes, M., van der Wal, B. C. H., & Vogely, H. C. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24422 · Cited by 109
Komatsu, N., & Takayanagi, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00077 · Cited by 118
Self-citationHayashi, T., Kaneda, T., Toyama, Y., Kumegawa, M., & Hakeda, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203836200 · Cited by 97
McCormick, R. K. (2007) · PubMed · Cited by 125
T cells: Critical bone regulators in health and disease
Pacifici, R. (2010) · Bone · doi:10.1016/j.bone.2010.04.611 · Cited by 94
Contributions of the Host Microenvironment to Cancer-Induced Bone Disease
Olechnowicz, S. W. Z., & Edwards, C. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2645 · Cited by 102
Tseng, H.-C., Kanayama, K., Kaur, K., Park, S., Park, S., Kozłowska, A. K., Sun, S., McKenna, C. E., Nishimura, I., & Jewett, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4755 · Cited by 92
Miranda‐Carús, M., Benito‐Miguel, M., Balsa, A., Cobo‐Ibáñez, T., Pérez De Ayala, C., Pascual‐Salcedo, D., & Martín‐Mola, E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21731 · Cited by 92
Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro
Wu, X., McKenna, M. A., Feng, X., Nagy, T. R., & McDonald, J. M. (2003) · Endocrinology · doi:10.1210/en.2003-0296 · Cited by 93
Estrogen Regulation of Immune Cell Bone Interactions
Weitzmann, M. N., & Pacifici, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.030 · Cited by 97
Senescence-associated secretory phenotype and its impact on oral immune homeostasis
Yue, Z., Nie, L., Zhao, P., Ji, N., Liao, G., & Wang, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019313 · Cited by 110
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 91
Pharmacophylogenomics: genes, evolution and drug targets
Searls, D. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1152 · Cited by 99
Metadata
- Authors
- Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., & Taniguchi, T.
- Affiliations
- The University of Tokyo (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Taniguchi, Tadatsugu
- ORCID
- Venue
- Nature
- Published
- 2000-11
- Volume
- 408
- Issue
- 6812
- Pages
- 600-605
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1639854378
- Cited by
- 1,358
- References
- 31
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 45 · 2023: 47 · 2022: 51 · 2021: 68 · 2020: 66 · 2019: 45 · 2018: 48 · 2017: 51 · 2016: 47 · 2015: 46 · 2014: 41 · 2013: 56 · 2012: 50
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- osteoclastogenesis, RANKL, interferon-gamma, T cells, TRAF6, NF-κB, JNK, ubiquitination, ubiquitin-proteasome system, bone resorption, bone homeostasis, autoimmune arthritis
- MeSH terms
- Animals, Arthritis, Autoantigens, Autoimmune Diseases, Bone Marrow Cells, Bone Resorption, Carrier Proteins, Cells, Cultured, Cysteine Endopeptidases, Glycoproteins, Interferon-gamma, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Multienzyme Complexes, Osteoclasts, Proteins, T-Lymphocytes, Ubiquitins, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Mitogen-Activated Protein Kinase Kinases, Proteasome Endopeptidase Complex, TNF Receptor-Associated Factor 6, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.